Euclid Advisors’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-22,109
Closed -$2.01M 531
2016
Q2
$2.01M Sell
22,109
-4,770
-18% -$404K 0.09% 274
2016
Q1
$2.28M Sell
26,879
-3,710
-12% -$276K 0.09% 263
2015
Q4
$2.42M Buy
30,589
+5,170
+20% +$407K 0.07% 257
2015
Q3
$1.79M Buy
25,419
+17,437
+218% +$1.43M 0.08% 160
2015
Q2
$720K Sell
7,982
-19,257
-71% -$1.86M 0.01% 365
2015
Q1
$2.74M Sell
27,239
-144,418
-84% -$14.6M 0.05% 255
2014
Q4
$17.3M Buy
171,657
+6,187
+4% +$617K 0.16% 123
2014
Q3
$15.9M Buy
165,470
+19,510
+13% +$1.85M 0.11% 178
2014
Q2
$13.6M Buy
+145,960
New +$12.8M 0.1% 211
2014
Q1
Sell
-116,500
Closed -$9.76M 508
2013
Q4
$9.76M Buy
+116,500
New +$9.49M 0.08% 234
2013
Q3
Sell
-90,000
Closed -$7.13M 539
2013
Q2
$7.13M Buy
+90,000
New +$7.22M 0.09% 235

Other funds holding MJN

Euclid Advisors's MJN Position: Q3 2016 in Review

Euclid Advisors sold out of Mead Johnson Nutrition Company (MJN) in Q3 2016, closing a stake of 22,109 shares — an estimated $2.01M sold.

Euclid Advisors first reported a position in MJN in Q2 2013 and held it in 11 quarters. The position peaked at $17.3M in Q4 2014. 536 funds tracked by Wall St. Rank hold MJN as of Q3 2016.

  • Euclid Advisors reported no remaining Mead Johnson Nutrition Company position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 22,109 Mead Johnson Nutrition Company shares in Q3 2016, an estimated $2.01M.
  • Euclid Advisors first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Mead Johnson Nutrition Company position peaked at $17.3M in Q4 2014.
  • 536 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.